1. Stocks
    2. /
  2. Pfizer Inc. (NYSE: PFE)
    3. /

Pfizer Inc. (NYSE: PFE) Share Price and News

$25.87 $0.07 (0.3%) 13 December 2025 at 7:58:58 am AEDT

Pfizer Inc. Chart and Price Data

About Pfizer

Last updated 13-12-2025, 07:58:58am AEDT
Current Price $25.87
Change $0.07 (0.3%)
Close Price $25.87
Open Price $25.84
Bid $25.86
Ask $25.87
Day Range $25.72 - $26.04
Year Range $20.92 - $27.69
Volume 1,150,608
Average Volume 67,841,689
Market Cap $146,975,603,500.00
Earnings Per Share $1.72

    • Pfizer Inc. (NYSE: PFE)
    Latest News

    A young man clasps his hand to his head with a pained expression on his face and a laptop computer in front of him.
    International Stock News

    3 subtle investing mistakes I won't repeat in 2025 and beyond

    | Alex Carchidi

    You can avoid the mistakes I made...

    Read more »

    A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
    International Stock News

    2 top trends to invest $2,000 in ahead of the crowd

    | Alex Carchidi

    These two trends on the frontier of medicine could present lucrative opportunities for investment.

    Read more »

    A child covering his eyes hiding from a toy bear representing a bear market for ASX shares
    International Stock News

    3 steps you'll regret not taking during this bear market

    | Alex Carchidi

    The last step is by far the hardest.

    Read more »

    a medical person in full protective clothing holds a tray of Covid-19 vaccinations amid a haze caused by cold and ice.
    Healthcare Shares

    ResApp share price frozen as $180m Pfizer takeover bid hangs in the balance

    | Brooke Cooper

    The value of Pfizer's takeover bid may soon come to light.

    Read more »

    Stethoscope with a piggy bank and hundred dollar notes.
    ETFs

    A defensive ASX ETF for a recessionary environment: experts

    | Bernd Struben

    In an ageing world newly aware of the potential threats posed by pandemics, healthcare shares have received plenty of attention…

    Read more »

    smiling health care workers in a medical setting
    Healthcare Shares

    Imugene (ASX:IMU) share price leaps 9% on Pfizer, Merck deal

    | Bernd Struben

    Cooperation between drug developers could speed up the delivery of effective treatments.

    Read more »

    four excited doctors with their hands in the air
    ETFs

    Expert reveals top pandemic ETF play – up 58% in 12 months

    | Bernd Struben

    COVID variants are likely to drive longer-term demand for mRNA vaccines.

    Read more »

    A businesman's hands surround a circular graphic with a United States flag and dollar signs, indicating buying and selling US shares
    Share Market News

    ASX investors were buying Alibaba, Pfizer shares last week

    | Sebastian Bowen

    Which US shares were ASX investors buying last week?

    Read more »

    A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
    Healthcare Shares

    Why the IDT (ASX:IDT) share price is rocketing 25% on Wednesday

    | Marc Sidarous

    The company claims it can make 100 million doses of mRNA vaccine within 18 months.

    Read more »

    girl receiving pfizer vaccine
    International Stock News

    Why Pfizer shot 4% higher on Tuesday

    | Eric Volkman

    New York City introduces a sweeping vaccination mandate, as authorities struggle to keep the coronavirus at bay.

    Read more »

    Bottle of tablets spilling over onto piles of US dollars
    International Stock News

    Why the Pfizer share price shot higher on Wednesday

    | Eric Volkman

    The company's powerful growth isn't only due to its coronavirus vaccine.

    Read more »

    Female patient receives Pfizer covid vaccine administered by female doctor
    Coronavirus News

    TGA approves Pfizer vaccine for kids aged 12-15 years old

    | Marc Sidarous

    The Therapeutics Goods Administration decided to approve the vaccine for kids late last night.

    Read more »

    Profile

    since

    Note